FDA Cuts Ambien Dosage After Sleep-Driving Incidents

The U.S. Food and Drug Administration has announced today that it is requiring manufacturers of Ambien, Ambien CR, Zolpimist, Edluar, and other sleeping medications that contain the active ingredient zolpidem, to lower currently recommended doses.